2019 Annual Meeting
Chicago, IL, USA
October 17-18

Mapping Neuroethics: An Expanded Vision

The 2019 Annual Meeting of the International Neuroethics Society (INS) will gather a diverse group of scholars, scientists, clinicians, and professionals dedicated to the responsible use of advances in brain science. Attendees will participate in intellectually stimulating and dynamic sessions that will explore neuroethics in a global context.



Janssen Neuroscience; Pharmaceutical companies of Johnson & Johnson
Stanley Center for Psychiatric Research at Broad Institute
The Kavli Foundation
Taylor & Francis; Taylor & Francis Group

Plenary Speakers


Image of Martha Farah


Martha J. Farah

Center for Neuroscience & Society
University of Pennsylvania



Image of Matt Baum


Matthew L. Baum

Harvard Medical School








Solving Dilemmas in Global Neuroethics

Presentations and a follow-up world cafe discussion with the full audience will examine several themes addressed in the perspective article, 'Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives' (Neuron, 2018). The goal of this session is to promote a productive dialogue on diverse ethical approaches to contemporary issues in global neuroethics.


Ethics and the Imprisoned Brain

As researchers begin to investigate techniques for altering inmates' brains to rid prisons of what Anthony Burgess called ‘the ultra-violence,’ the ongoing neuroethics discourse about biological approaches to criminal justice takes on renewed urgency. Speakers will address the promise and peril of neuro-interventions for incarcerated persons, whether in research and development or implementation and oversight.



Incapable Patients and Psychiatric Neurosurgery: What do Law and Ethics Have to Say?

Many laws define psychosurgery to include deep brain stimulation (DBS) for psychiatric indications, a field under intensive exploration and expansion. This session will consider the history, present and future, of the regulation of invasive psychiatric neuromodulation such as DBS, with particular attention to the questions of whether there is a need for specific law, and what its optimal contents should be.



Preclinical Interventions in Psychiatric and Neurological Disorders

As we get better at using genetic, metabolic or behavioral biomarkers to predict future susceptibility for neurological and psychiatric syndromes, the problem of medical management of people in such preclinical states becomes more trenchant. Testing preventive drugs, informing patients or parents of risks, managing false positives, and treating patients with little discernible illness raise significant ethical questions that we will discuss with a panel of experts.


Disorders of Consciousness: Concepts, Culture and Prognosis

This session will explore the importance of concepts when addressing disorders of consciousness. Speakers will discuss the cultural dimensions and ethical implications of selecting concepts, how concepts can impact practice protocol and medical decision-making, and the potential consequences of categorizing patients.


View the meeting program for a complete schedule and list of confirmed speakers. Registration is now open. Subscribe to receive email announcements about the program and speakers.


Meeting Program




The INS annual meeting brings together people from around the world with shared goals in neuroethics

Ilina Singh and Arleen Salles are co-chairs of the Program Committee for the 2019 INS Annual Meeting. Their task is to put together a dynamic program of panel discussions, lectures, and opportunities for networking. Some ideas may challenge conventional thinking on neuroethics issues. Ilina, Arleen, and their committee members have put a major emphasis on inclusion, diversity, and culture to create an INS meeting that truly represents the 'international' nature of our Society. — Full Interview

Image of Martha Farah

The brain and socioeconomic status: how do we apply it to real-world policy?

Martha J. Farah is the Walter H. Annenberg Professor of Natural Sciences at the Center for Neuroscience & Society, University of Pennsylvania. She is a cognitive neuroscientist who works on problems at the interface of neuroscience and society. Farah will give the Fred Kavli Distinguished Neuroethics Lecture at the 2019 INS Annual Meeting. — Interview

Image of Matt Baum

Neurotechnology produces a better diagnosis, but what are the ethical implications for people with mental illness?

Matthew Baum is an MD-PhD student at Harvard Medical School. He graduated from the Molecular, Cellular and Developmental Biology department at Yale University, then studied neuroscience at Trinity College Dublin in Ireland and completed a D.Phil. in neuroethics at the University of Oxford in the U.K. He completed the PhD Program in Neuroscience at Harvard University where he investigated neural–immune interactions in the development of psychiatric disease and is now finishing his medical training with a plan to specialize in psychiatry. Baum will be giving the opening lecture at the annual meeting. — Interview

Image of Jennifer Chandler

Working at the Intersection of Brain Science, Law and Ethics

Jennifer Chandler is internationally recognized for her research and writing in the law and ethics of brain sciences. She holds the Bertram Loeb Research Chair at the University of Ottawa in Canada and has launched Neuroethics-Panamericana, a group of clinicians, ethicists, and social scientists who are collaborating on the regulation of neuromodulation. She is an elected member of the INS Board of Directors. — Interview

Image of Roland Nadler

Neuroscience may help curb prison violence – but should it?

Roland Nadler, JD, is starting a doctorate program in law at the University of British Columbia. He was formerly visiting professor at the University of Ottawa in the Center for Health, Law, Policy and Ethics. He will moderate a panel discussion on 'Ethics and the Imprisoned Brain.' — Interview


photo array